These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1169271)

  • 1. Report of a workshop: disease accentuation after immunization with inactivated microbial vaccines.
    Craighead JE
    J Infect Dis; 1975 Jun; 131(6):749-54. PubMed ID: 1169271
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vaccinal measles process in children during the manifestations of acute respiratory diseases].
    Sergeeva MV; Vorotyntseva NV; Titova NS
    Pediatriia; 1991; (10):57-61. PubMed ID: 1788003
    [No Abstract]   [Full Text] [Related]  

  • 3. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine.
    Kapikian AZ; Mitchell RH; Chanock RM; Shvedoff RA; Stewart CE
    Am J Epidemiol; 1969 Apr; 89(4):405-21. PubMed ID: 4305197
    [No Abstract]   [Full Text] [Related]  

  • 4. [Complement fixation reaction for Mycoplasma pneumoniae in the serologic diagnosis of respiratory diseases].
    Martelli A
    G Batteriol Virol Immunol Microbiol; 1972 Jan; 65(1):43-9. PubMed ID: 4364789
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of inactivated Mycoplasma pneumoniae vaccine in man.
    Mogabgab WJ; Marchand S; Mills G; Beville R
    Dev Biol Stand; 1975; 28():597-608. PubMed ID: 1126587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination against acute respiratory virus infections and measles in man.
    Osterhaus AD; de Vries P
    Immunobiology; 1992 Feb; 184(2-3):180-92. PubMed ID: 1587542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serologic profile of children in a Mexican highland community: prevalence of complement-fixing antibodies to Mycoplasma pneumoniae, respiratory syncytial virus and parainfluenza viruses.
    Golubjatnikov R; Allen VD; Olmos-Blancarte MP; Inhorn SL
    Am J Epidemiol; 1975 May; 101(5):458-64. PubMed ID: 165720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory virus vaccines. V. Field evaluation for efficacy of heptavalent vaccine.
    Weibel RE; Stokes J; Leagus MB; Mascoli CC; Hilleman MR
    Am Rev Respir Dis; 1966 Sep; 94(3):362-79. PubMed ID: 4288226
    [No Abstract]   [Full Text] [Related]  

  • 9. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine.
    Kim HW; Canchola JG; Brandt CD; Pyles G; Chanock RM; Jensen K; Parrott RH
    Am J Epidemiol; 1969 Apr; 89(4):422-34. PubMed ID: 4305198
    [No Abstract]   [Full Text] [Related]  

  • 10. Respiratory virus vaccines. 3. Pentavalent respiratory syncytial-parainfluenza-mycoplasma pneumoniae vaccine.
    Sweet BH; Tytell AA; Potash L; Weibel RE; Stokes J; Drake ME; Woodhour AF; Hilleman MR
    Am Rev Respir Dis; 1966 Sep; 94(3):340-9. PubMed ID: 4288342
    [No Abstract]   [Full Text] [Related]  

  • 11. Associated seroconversions to respiratory viruses in volunteers with experimental influenza infection.
    Rudenko LG; Shadrin AS; Geiker VI; Zibina EA; Zykov MP
    Acta Virol; 1976 Apr; 20(2):135-41. PubMed ID: 5868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine.
    Fulginiti VA; Eller JJ; Sieber OF; Joyner JW; Minamitani M; Meiklejohn G
    Am J Epidemiol; 1969 Apr; 89(4):435-48. PubMed ID: 4305199
    [No Abstract]   [Full Text] [Related]  

  • 13. Update: vaccine side effects, adverse reactions, contraindications, and precautions. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1996 Sep; 45(RR-12):1-35. PubMed ID: 8801442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of acute mycoplasmal and viral respiratory tract disease.
    Chanock RM
    Science; 1970 Jul; 169(3942):248-56. PubMed ID: 4317229
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunity to mycoplasmas causing respiratory diseases in man and animals.
    Whittlestone P
    Adv Vet Sci Comp Med; 1976; 20():277-307. PubMed ID: 795287
    [No Abstract]   [Full Text] [Related]  

  • 16. Inactivated myxovirus vaccines, atypical illness, and delayed hypersensitivity.
    Eller JJ
    J Pediatr; 1969 Apr; 74(4):664-6. PubMed ID: 4304439
    [No Abstract]   [Full Text] [Related]  

  • 17. [A special immunization clinic tailors vaccinations].
    Aronsson B; Blennow M
    Lakartidningen; 2008 May 28-Jun 3; 105(22):1675-9. PubMed ID: 18590010
    [No Abstract]   [Full Text] [Related]  

  • 18. Differences in the appearance of antibodies to structural components of measles virus after immunization with inactivated and live virus.
    Norrby E; Enders-Ruckle G; Meulen V
    J Infect Dis; 1975 Sep; 132(3):262-9. PubMed ID: 1159329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indicators of humoral immunity to M. pneumoniae in healthy children and in children with respiratory tract infections].
    Korzhenkova MP; Vorotyntseva NV; Lozovskaia LS; Mirishli AD; Rybakova II
    Vopr Okhr Materin Det; 1974 Nov; 19(11):16-21. PubMed ID: 4612965
    [No Abstract]   [Full Text] [Related]  

  • 20. Respiratory virus vaccines. IV. Heptavalent respiratory syncytial-parainfluenza-mycoplasma-influenza vaccine in institutionalized persons.
    Woodhour AF; Sweet BH; Tytell AA; Potash L; Stokes J; Weibel RE; Metzgar DP; Hilleman MR
    Am Rev Respir Dis; 1966 Sep; 94(3):350-61. PubMed ID: 4288225
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.